Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fungal diagnostics, pathogenesis and chemotherapy symposia.

N H Georgopapadakou1

  • 1DuPont Merck Research Labs, Experimental Station E400/3442, Rt 141 & Henry Clay Road, PO Box 80400, Wilmington, DE 19800-0400, USA. nafsikag@aol.com

Idrugs : the Investigational Drugs Journal
|October 4, 2005
PubMed
Summary

This report reviews new developments in fungal diagnostics, pathogenesis, and antifungal chemotherapy. It highlights emerging treatments in both early research and clinical trials for fungal infections.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Update on antifungals targeted to the cell wall: focus on beta-1,3-glucan synthase inhibitors.

Expert opinion on investigational drugs·2001
Same author

Antifungals targeted to sphingolipid synthesis: focus on inositol phosphorylceramide synthase.

Expert opinion on investigational drugs·2000
Same author

Inhibition of inositol phosphorylceramide synthase by aureobasidin A in Candida and Aspergillus species.

Antimicrobial agents and chemotherapy·2000
Same author

Inhibition of yeast inositol phosphorylceramide synthase by aureobasidin A measured by a fluorometric assay.

FEBS letters·1999
Same author

Antifungals: mechanism of action and resistance, established and novel drugs.

Current opinion in microbiology·1999
Same author

Antifungals targeted to the cell wall.

Expert opinion on investigational drugs·1997

Area of Science:

  • Mycology
  • Infectious Diseases
  • Pharmacology

Background:

  • Fungal infections pose a significant global health challenge.
  • Antifungal therapies are crucial for managing invasive mycoses.
  • Continuous innovation in diagnostics and treatment is needed.

Purpose of the Study:

  • To summarize recent advancements in fungal diagnostics.
  • To discuss the pathogenesis of fungal infections.
  • To review the development of antifungal chemotherapy, including new agents.

Main Methods:

  • Review of symposia presentations and proceedings.
  • Focus on preclinical and clinical development of antifungal agents.
  • Synthesis of information on established and novel therapeutic strategies.

Related Experiment Videos

Main Results:

  • New diagnostic tools for fungal identification are emerging.
  • Understanding of fungal pathogenesis is advancing.
  • Several new antifungal agents are in various stages of development.

Conclusions:

  • Significant progress is being made in antifungal diagnostics and treatment.
  • Novel therapeutic strategies show promise for combating fungal infections.
  • Continued research and development are essential for addressing antifungal resistance and improving patient outcomes.